20 October 2023
Unveiling the Unseen Struggles: A Comprehensive Review of Vitiligo’s Psychological, Social, and Quality of Life Impacts
Abstract This review explores the psychosocial impact of vitiligo on…
20 October 2023
Upadacitinib Meets Primary End Point of Phase 2 Trial for Vitiligo and Advances to Phase 3
AbbVie recently announced that its phase 2b study investigating upadacitinib (Rinvoq)…
20 October 2023
Worldwide expert recommendations for the diagnosis and management of vitiligo Part 2
Abstract Background The treatment of vitiligo can be challenging. Up-to-date…
20 October 2023
Worldwide expert recommendations for the diagnosis and management of vitiligo Part 1
Abstract Background The treatment of vitiligo can be challenging and…
20 October 2023
Disease Burden and Management of Vitiligo
Vitiligo is a skin disease characterized by selective loss of…
20 October 2023
Quality of life of adult vitiligo patients using camouflage: A survey in a Chinese vitiligo community
Abstract Background Vitiligo is an acquired depigmented skin disease…
26 September 2023
Mental Health and Psychosocial Quality-of-Life Burden Among Patients With Vitiligo Findings From the Global VALIANT Study
Kristen Bibeau, PhD, MSPH; Khaled Ezzedine,MD, PhD; John E. Harris,…
26 September 2023
Advances in vitiligo: Update on therapeutic targets
Yifei Feng Yan Lu* Department of Dermatology, Jiangsu Province People’s Hospital…
6 September 2023
Vitiligo Treatment and Management
Vitiligo is a complex autoimmune disease that requires understanding and…
31 August 2023
World Congress of Dermatology 2023
Our president Mrs Gaone Matewa and the board member Dr…
